Efficacy and safety of first-line bevacizumab combined with paclitaxel in 220 patients with metastatic breast cancer: The Hungarian AVAREG observational study

被引：0
作者：
Dank, Magdolna
Budi, Laszlo
Landherr, Laszlo
Piko, Bela
Mangel, Laszlo
Erfan, Jozsef
Cseh, Jozsef
Ruzsa, Agnes
Nagy, Andras
机构：
[1] Semmelweis Univ, H-1085 Budapest, Hungary
[2] BAZ Cty Hosp, Miskolc, Hungary
[3] Uzsoki St Hosp, Budapest, Hungary
[4] Bekes Cty Pandy Kalman Hosp, Gyula, Hungary
[5] Univ Pecs, Fac Med, Pecs, Hungary
[6] Josa Andras Oktata Korhaz, Nyiregyhaza, Hungary
[7] Fejer Cty St George Hosp, Szekesfehervar, Hungary
[8] Zala Cty Hosp, Zalaegerszeg, Hungary
[9] Roche Hungary Ltd, Budaors, Hungary
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e12022
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Efficacy and safety of bevacizumab in combination with irinotecan and capecitabine in first-line treatment of metastatic colorectal cancer
    Jungic, Sasa
    Tubic, Biljana
    Gajanin, Radoslav
    Gojkovic, Zdenka
    Rakita, Ivanka
    VOJNOSANITETSKI PREGLED, 2017, 74 (03) : 249 - 255
  • [42] Safety and efficacy of first-line bevacizumab with FOLFOX, XELOX, FOLFIRI and fluoropyrimidines in metastatic colorectal cancer: the BEAT study
    Van Cutsem, E.
    Rivera, F.
    Berry, S.
    Kretzschmar, A.
    Michael, M.
    DiBartolomeo, M.
    Mazier, M. -A.
    Canon, J. -L.
    Georgoulias, V.
    Peeters, M.
    Bridgewater, J.
    Cunningham, D.
    ANNALS OF ONCOLOGY, 2009, 20 (11) : 1842 - 1847
  • [43] SAFETY AND EFFICACY OF BEVACIZUMAB WITH FIRST-LINE FOLFIRI FOR METASTATIC COLORECTAL CANCER: SINGLE CENTER EXPERIENCE
    De Sanctis, R.
    Longo, F.
    Gori, B.
    Zivi, A.
    Del Signore, E.
    Proietti, E.
    De Filippis, L.
    Stumbo, L.
    Quadrini, S.
    Di Seri, M.
    ANNALS OF ONCOLOGY, 2008, 19 : 145 - 145
  • [44] Safety and efficacy of first-line gemcitabine plus nab-paclitaxel for elderly metastatic pancreatic cancer patients
    Pecora, I.
    Vivaldi, C.
    Rovesti, G.
    Catanese, S.
    Salani, F.
    Gardini, A. Casadei
    Massa, V.
    Bernardini, L.
    Riggi, M.
    Andrikou, K.
    Rapposelli, I.
    Formica, V.
    Cesario, S.
    Caccese, M.
    Lencioni, M.
    Vasile, E.
    Falcone, A.
    Fornaro, L.
    ANNALS OF ONCOLOGY, 2020, 31 : S151 - S151
  • [45] First-line bevacizumab in combination with weekly paclitaxel for metastatic breast cancer: efficacy and safety results from a large, open-label, single-arm Japanese study
    Aogi, Kenjiro
    Masuda, Norikazu
    Ohno, Shinji
    Oda, Takashi
    Iwata, Hiroji
    Kashiwaba, Masahiro
    Fujiwara, Yasuhiro
    Kamigaki, Shunji
    Ito, Yoshinori
    Ueno, Takayuki
    Takashima, Shigemitsu
    BREAST CANCER RESEARCH AND TREATMENT, 2011, 129 (03) : 829 - 838
  • [46] Effect of bevacizumab combined with first-line chemotherapy on metastatic colorectal cancer
    Xiong, Lifeng
    Lou, Yinmei
    Wang, Lin
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2021, 13 (04): : 3609 - 3617
  • [47] Safety and efficacy of first-line bevacizumab combined with taxane therapy in Chinese patients with HER2-negative locally recurrent or metastatic breast cancer: findings from the ATHENA study
    Xu Bing-he
    Jiang Ze-fei
    Shen Zhen-zhou
    Guan Zhong-zhen
    Chen Zheng-dong
    Cheng Ying
    Zheng Hong
    Jiang Jun
    Wang Xiao-jia
    Tong Zhong-sheng
    Qin Shu-kui
    Luo Yi
    Yao Min
    Wang Li-wei
    He Jing
    CHINESE MEDICAL JOURNAL, 2012, 125 (05) : 764 - 769
  • [48] Safety and efficacy of bevacizumab with first-line FOLFIRI for metastatic colorectal cancer: Single center experience
    Longo, F.
    De Sanctis, R.
    Quadrini, S.
    Stumbo, L.
    Del Signore, E.
    Gori, B.
    De Filippis, L.
    Di Seri, M.
    ANNALS OF ONCOLOGY, 2008, 19 : 91 - 92
  • [49] Efficacy and safety of bevacizumab with standard first-line fluoropyrimidine-based chemotherapy in patients with metastatic colorectal cancer: First beat
    Rivera, F.
    Cunningham, D.
    Berry, S.
    Kretzschmar, A.
    Michael, M.
    Dibartolomeo, M.
    Mazier, M.
    Andre, N.
    Van Cutsem, E.
    ANNALS OF ONCOLOGY, 2008, 19 : 17 - 17
  • [50] MicroRNAs correlating with outcome in patients treated with first-line bevacizumab for metastatic breast cancer
    Gampenrieder, Simon P.
    Hamacher, Frank
    Rinnerthaler, Gabriel
    Hufnagl, Clemens
    Hackl, Hubert
    Romeder, Franz
    Muss, Claudia
    Hauser-Kronbeger, Cornelia
    Mlineritsch, Brigitte
    Greil, Richard
    CANCER RESEARCH, 2015, 75
12345